Do weight loss injections make you feel sick? Here's what actually happens

The first week: when it tends to hit hardest

Picture this: it is three days into your first pen. You have eaten a normal-sized dinner and within an hour you feel uncomfortably full, slightly queasy, and vaguely sorry you ordered dessert. That is the scenario most people describe on tirzepatide (Mounjaro) or semaglutide (Wegovy) in the early weeks, not violent sickness for most, but a persistent, low-level nausea that sits somewhere between car-sickness and having eaten too fast.

This is not a surprise to prescribers, and it is not a red flag. GLP-1 receptor agonists (and tirzepatide, which also activates the GIP receptor) slow the rate at which food moves from the stomach into the small intestine. The stomach stays fuller for longer, which is exactly why appetite falls. The same slowing is what makes some people feel queasy. The NHS medicines guidance on tirzepatide lists nausea, vomiting, diarrhoea, constipation, indigestion, burping and fatigue among the commonly reported effects, particularly at the start of treatment or after a dose step up.

Symptoms are generally most noticeable in the first few days after each new dose, then settle. Treatment typically starts at a low dose (2.5 mg for tirzepatide) precisely because the lower the dose, the gentler the introduction. A question our prescribers hear regularly is whether the nausea means the medicine is not agreeing with you. For the majority of people, it means it is working. The pattern of GI symptoms and how to manage them is covered in more detail separately.

Not just nausea: the full picture of what people report

Sickness is the headline, but it travels with company. Constipation and diarrhoea can both occur (sometimes alternating) along with bloating, acid reflux, and an occasional metallic taste. Fatigue and headaches turn up in trial data too, though these are less consistently reported and often settle faster than the GI effects.

There is a misconception worth naming gently here: some people assume that feeling sick means the medicine is damaging their stomach. It is not. These symptoms are pharmacological rather than structural, the medicine is doing what it is supposed to, and the gut is adjusting. The stomach lining is not being irritated; the nerves and hormones that regulate appetite and digestion are simply receiving a new signal.

A smaller number of people experience very little nausea at all. Individual responses vary considerably, and there is no reliable way to predict in advance which camp someone will fall into. What the evidence does show consistently (across both the SURMOUNT-1 tirzepatide trial and the STEP 1 semaglutide study, both published in the New England Journal of Medicine) is that the majority of participants who discontinued due to side effects did so in the first few weeks. People who get through that window tend to stay.

If you are also curious about less-discussed effects, fatigue on weight loss injections and temporary hair thinning are topics covered in our related pages.

When 'sick' tips into something that needs attention

Most nausea with weight loss injections is unpleasant but benign. There are exceptions, and knowing them matters. Severe or prolonged vomiting can lead to dehydration, which puts strain on the kidneys, if you cannot keep fluids down for more than a day, that warrants a call to a healthcare professional rather than waiting it out.

More importantly: if you develop severe stomach pain that radiates to your back, with or without vomiting, stop and seek urgent medical help. In January 2026, the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis as a known but infrequent risk with GLP-1 medicines, rare, but serious enough to act on quickly if the symptom pattern fits. This is not typical nausea; the pain is usually intense and does not pass on its own.

Gallbladder symptoms (pain in the upper right abdomen, sometimes after eating) are also worth raising with a prescriber. These are listed in the safety profile of both medicines. None of this means you should expect serious complications; the vast majority of people do not experience them. It means knowing the difference between the predictable and the urgent.

If you have a concern that feels outside the ordinary side-effect window, our aftercare team is available seven days a week.

Practical steps that genuinely help

Clinical trials and real-world experience point to a few consistent patterns for keeping GI symptoms manageable. Smaller meals make a measurable difference: the stomach is already processing more slowly, so loading it with a large portion compounds the problem. Eating slowly matters for the same reason. High-fat foods (particularly fried or very rich meals) seem to worsen nausea more than other foods, possibly because fat is the slowest macronutrient to leave the stomach under normal conditions and becomes slower still on these medicines.

Injecting in the evening before bed means the peak period of nausea (typically the first twelve to twenty-four hours after a dose) happens while you are asleep. Not everyone finds this makes a difference, but enough people do that it is worth trying if mornings are bad. Hydration is straightforward: sip water consistently rather than drinking in large amounts, which can itself trigger nausea when the stomach is sensitive.

Protein intake deserves a mention here. Rapid weight loss on any treatment carries a risk of losing lean muscle alongside fat, and protein helps protect against that, what happens to muscle on weight loss injections is a question worth reading about. Keeping protein adequate also tends to stabilise appetite through the day, which can reduce the cycle of undereating then overeating that sometimes worsens GI symptoms.

For a broader view of what to weigh up before starting, our consultation page is the right place to look. A prescriber at nume will go through your medical history, the likely side-effect profile for you specifically, and any adjustments worth considering, including timing of injection and how to approach dose increases.